Table 1.
Hemostatic success of Hemopatch® and Surgicel® Original in VIBe SCALE grade 1 and grade 2 bleeding during the 10-min observation period post-application
Time (min) | Overall (VIBe SCALE grade 1/2) | VIBe SCALE grade 1 | VIBe SCALE grade 2 | |||
---|---|---|---|---|---|---|
Hemopatch® (N = 198) | Surgicel® Original (N = 199) | Hemopatch® (N = 99) | Surgicel® Original (N = 100) | Hemopatch® (N = 99) | Surgicel® Original (N = 99) | |
n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |
2 | 142 (71.7) | 101 (50.8) | 94 (94.9) | 95 (95.0) | 48 (48.5) | 6 (6.1) |
3 | 146 (73.7) | 107 (53.8) | 94 (94.9) | 95 (95.0) | 52 (52.5) | 12 (12.1) |
5 | 153 (77.3) | 122 (61.3) | 94 (94.9) | 95 (95.0) | 59 (59.6) | 27 (27.3) |
7 | 159 (80.3) | 131 (65.8) | 94 (94.9) | 95 (95.0) | 65 (65.7) | 36 (36.4) |
10 | 166 (83.8) | 146 (73.4) | 95 (96.0) | 98 (98.0) | 71 (71.7) | 48 (48.5) |